188 related articles for article (PubMed ID: 35505107)
1. Revisiting the spectrum of IgM-related neuropathies in a large cohort of IgM monoclonal gammopathy.
Bardel B; Molinier-Frenkel V; Le Bras F; Ayache SS; Nordine T; Lefaucheur JP; Planté-Bordeneuve V
J Neurol; 2022 Sep; 269(9):4955-4960. PubMed ID: 35505107
[TBL] [Abstract][Full Text] [Related]
2. Neuropathy associated with "benign" anti-myelin-associated glycoprotein IgM gammopathy: clinical, immunological, neurophysiological pathological findings and response to treatment in 33 cases.
Ellie E; Vital A; Steck A; Boiron JM; Vital C; Julien J
J Neurol; 1996 Jan; 243(1):34-43. PubMed ID: 8869385
[TBL] [Abstract][Full Text] [Related]
3. Immunostaining of skin biopsy adds no diagnostic value in MGUS-associated peripheral neuropathy.
Al-Zuhairy A; Schrøder HD; Plesner T; Abildgaard N; Sindrup SH
J Neurol Sci; 2015 Feb; 349(1-2):60-4. PubMed ID: 25582978
[TBL] [Abstract][Full Text] [Related]
4. [Anti-myelin-associated glycoprotein antibody positive IgM monoclonal gammopathy related peripheral neuropathy: 11 cases and literature review].
Gao XM; Jia MN; Qian M; Ren HT; Zhang L; Shen KN; Cao XX; Li J
Zhonghua Xue Ye Xue Za Zhi; 2019 Nov; 40(11):901-905. PubMed ID: 31856437
[No Abstract] [Full Text] [Related]
5. Polyneuropathy and monoclonal gammopathy of undetermined significance (MGUS); update of a clinical experience.
Matà S; Torricelli S; Barilaro A; Grippo A; Forleo P; Del Mastio M; Sorbi S
J Neurol Sci; 2021 Apr; 423():117335. PubMed ID: 33647732
[TBL] [Abstract][Full Text] [Related]
6. [Neuropathy associated with dysglobulinemia and monoclonal gammopathy].
Saito T
Nihon Rinsho; 1994 Nov; 52(11):2976-83. PubMed ID: 7996697
[TBL] [Abstract][Full Text] [Related]
7. Neuropathy associated with monoclonal gammopathies of undetermined significance.
Gosselin S; Kyle RA; Dyck PJ
Ann Neurol; 1991 Jul; 30(1):54-61. PubMed ID: 1656848
[TBL] [Abstract][Full Text] [Related]
8. Polyneuropathy with monoclonal gammopathy: glycolipids are frequently antigens for IgM paraproteins.
Ilyas AA; Quarles RH; Dalakas MC; Brady RO
Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6697-700. PubMed ID: 2413445
[TBL] [Abstract][Full Text] [Related]
9. Serum neurofilament light chain, contactin-1 and complement activation in anti-MAG IgM paraprotein-related peripheral neuropathy.
Amaador K; Wieske L; Koel-Simmelink MJA; Kamp A; Jongerius I; de Heer K; Teunissen CE; Minnema MC; Notermans NC; Eftimov F; Kersten MJ; Vos JMI
J Neurol; 2022 Jul; 269(7):3700-3705. PubMed ID: 35157138
[TBL] [Abstract][Full Text] [Related]
10. Clinical, electrophysiological and immunological study of peripheral nerves in Egyptian patients with monoclonal gammopathies.
El-Difrawy MM; Zaki NE; Marouf HM; Ayad MW; Farag AM
Int J Hematol; 2012 Jan; 95(1):71-6. PubMed ID: 22193843
[TBL] [Abstract][Full Text] [Related]
11. Clinical and laboratory features of anti-MAG neuropathy without monoclonal gammopathy.
Pascual-Goñi E; Martín-Aguilar L; Lleixà C; Martínez-Martínez L; Simón-Talero MJ; Díaz-Manera J; Cortés-Vicente E; Rojas-García R; Moga E; Juárez C; Illa I; Querol L
Sci Rep; 2019 Apr; 9(1):6155. PubMed ID: 30992531
[TBL] [Abstract][Full Text] [Related]
12. The clinical spectrum of IgM monoclonal gammopathy: A single center retrospective study of 377 patients.
Cao XX; Meng Q; Mao YY; Su W; Zhen JF; Shen KN; Zhang CL; Huang XF; Duan MH; Zhang W; Zhu TN; Cai HC; Chen M; Zhou DB; Li J
Leuk Res; 2016 Jul; 46():85-8. PubMed ID: 27232065
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal Gammopathies of 'Neurological Significance': Paraproteinemic Neuropathies.
Mani AM; Devasia AJ; Nair A; Benjamin RN; Prabhakar AT; Sivadasan A; Mathew V; Aaron S; George B; Alexander M
Can J Neurol Sci; 2021 Sep; 48(5):616-625. PubMed ID: 33397535
[TBL] [Abstract][Full Text] [Related]
14. Polyneuropathy associated with IgM monoclonal gammopathy: a review. Clinical, electrophysiological and pathological features.
Leger JM; Vaunaize J
Nouv Rev Fr Hematol (1978); 1990; 32(5):303-6. PubMed ID: 1965990
[TBL] [Abstract][Full Text] [Related]
15. Long-term clinical and neurophysiological follow-up of patients with peripheral, neuropathy associated with benign monoclonal gammopathy.
Ponsford S; Willison H; Veitch J; Morris R; Thomas PK
Muscle Nerve; 2000 Feb; 23(2):164-74. PubMed ID: 10639606
[TBL] [Abstract][Full Text] [Related]
16. Polyneuropathy associated with monoclonal gammopathy of undetermined significance: further evidence that IgM-MGUS neuropathies are different than IgG-MGUS.
Suarez GA; Kelly JJ
Neurology; 1993 Jul; 43(7):1304-8. PubMed ID: 8327128
[TBL] [Abstract][Full Text] [Related]
17. Investigation and Management of Immunoglobulin M- and Waldenström-Associated Peripheral Neuropathies.
Tomkins O; Leblond V; Lunn MP; Viala K; Weil DR; D'Sa S
Hematol Oncol Clin North Am; 2023 Aug; 37(4):761-776. PubMed ID: 37385714
[TBL] [Abstract][Full Text] [Related]
18. Anti-sulfatide/galactocerebroside antibodies in immunoglobulin M paraproteinemic neuropathies.
Boso F; Ruggero S; Giannotta C; Benedetti L; Marfia GA; Ermani M; Campagnolo M; Salvalaggio A; Gallia F; De Michelis C; Visentin A; Bianco M; Ruiz M; Mataluni G; Nobile-Orazio E; Briani C
Eur J Neurol; 2017 Nov; 24(11):1334-1340. PubMed ID: 28782863
[TBL] [Abstract][Full Text] [Related]
19. Characterization of neuropathies associated with elevated IgM serum levels.
Goldfarb AR; Sander HW; Brannagan TH; Magda P; Latov N
J Neurol Sci; 2005 Feb; 228(2):155-60. PubMed ID: 15694197
[TBL] [Abstract][Full Text] [Related]
20. Clinical phenotype of patients with neuropathy associated with monoclonal gammopathy: a comparative study and a review of the literature.
Stork AC; van der Pol WL; Franssen H; Jacobs BC; Notermans NC
J Neurol; 2014 Jul; 261(7):1398-404. PubMed ID: 24781837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
